Feedback / Questions
Ryoncil (remestemcel-L) - Mallinckrodt, Mesoblast
https://www.globenewswire.com/news-release/2025/12/11/3204384/0/en/Independent-Study-Presented-at-American-Society-of-Hematology-ASH-Annual-Meeting-Concludes-Remestemcel-L-Superior-to-Ruxolitinib-in-Clinical-Outcomes-as-Treatment-for-SR-aGvHD.html?_gl=1*7d369p*_up*MQ..*_ga*MTI4ODc5NjQ1NS4xNzY1NTc0MzE2*_ga_ERWPGTJ5X8*czE3NjU1NzQzMTUkbzEkZzAkdDE3NjU1NzQzMTUkajYwJGwwJGgw
Dec 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next